This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Rigrodsky & Long, P.A. Continues Investigation Regarding Acquisition Of Zoll Medical Corporation By Asahi Kasei Corporation

Rigrodsky & Long, P.A., a national securities firm with offices in Delaware and New York, announces that it is continuing its investigation of potential claims against the board of directors of Zoll Medical Corporation (“Zoll” or the “Company”) (NASDAQ GS: ZOLL). The investigation concerns possible breaches of fiduciary duty and other violations of law related to the Company’s entry into an agreement to be acquired by Asahi Kasei Corporation (“Asahi”).

Under the proposed agreement, on March 26, 2012, Asahi commenced a cash tender offer to purchase all of the outstanding shares of Zoll’s common stock for $93.00 per share. At least one analyst, however, has set a price target of $100.00 per share for Zoll’s stock, raising concerns whether Zoll’s board of directors adequately shopped the Company to obtain the best price possible for Zoll’s shareholders before entering into the agreement with Asahi and disclosed all material facts to shareholders about the transaction.

If you own the common stock of Zoll and purchased your shares before March 12, 2012, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Scott J. Farrell, Esquire of Rigrodsky & Long, P.A., 825 East Gate Boulevard, Suite 300, Garden City, New York 11530 toll free at (888) 969-4242, by e-mail to info@rigrodskylong.com, or at: http://www.rigrodskylong.com/investigations/zoll-medical-corporation-zoll

Rigrodsky & Long, P.A., with offices in Wilmington, Delaware and Garden City, New York, regularly litigates securities class, derivative and direct actions, shareholder rights litigation and corporate governance litigation, including claims for breach of fiduciary duty and proxy violations in the Delaware Court of Chancery and in state and federal courts throughout the United States.

Attorney advertising. Prior results do not guarantee a similar outcome.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,150.37 +70.23 0.39%
S&P 500 2,124.88 +7.19 0.34%
NASDAQ 5,115.39 +23.3050 0.46%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs